Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Steve Cohen's Point72 Boosts Stake in Beaten-Down Biotech Stock by 5,100% Despite Disappointing Trial Results

IBTimes - 20 Jul 2026 13:59
Billionaire Steve Cohen still backs biotech Evommune despite trial setbacks, highlighting its potential for treating chronic conditions and its strategic role in his portfolio.
Full Article at IBTimes

More Technology News
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard